BioCentury | Apr 22, 2013
Emerging Company Profile

Cardiorentis: Keeping heart

...Elmar Schnee told BioCentury. PDL BioPharma Inc. gained the program through its 2005 acquisition of ESP Pharma Inc....
BioCentury | Mar 17, 2008
Finance

Ebb & Flow

...Capital; and ESP Equity Partners. In 2003, GE Healthcare Financial Services helped finance EKR's predecessor, ESP Pharma...
BioCentury | Feb 11, 2008
Strategy

Sell high, buy low

...PDL BioPharma Inc. may not have gotten what it wanted from its 2005 purchase of ESP Pharma Inc....
BioCentury | Sep 3, 2007
Finance

PDL's downside surprise

...sales in 4Q07 or 1Q08. The marketed products came to PDLI through its acquisition of ESP Pharma Inc....
BioCentury | Aug 27, 2007
Finance

Ebb & Flow

...of Susquehanna, who upgraded from neutral to positive, valued a potential sale of the company's ESP Pharma...
BioCentury | May 14, 2007
Finance

Queen moves in PDL chess game

...2003 & Oct. 6, 2003). In last week's letter, Queen wrote that PDLI's purchase of ESP Pharma Inc....
BioCentury | Mar 12, 2007
Finance

Ebb & Flow

...and expeditious product development, you made what we consider to be an ill-conceived purchase of ESP Pharma,"...
BioCentury | Jan 22, 2007
Strategy

The ESP effect

...The ESP effect PDL BioPharma had a 95% runup from the time it acquired ESP Pharma in...
BioCentury | Jan 22, 2007
Strategy

Reset button

...channel. In 2005, he turned the company into a commercial enterprise with the acquisition of ESP Pharma Inc....
BioCentury | Jan 8, 2007
Finance

Value vs. opportunity

...thinks "expectations are low" for the products that PDLI gained from its 2005 acquisition of ESP Pharma...
Items per page:
1 - 10 of 54
BioCentury | Apr 22, 2013
Emerging Company Profile

Cardiorentis: Keeping heart

...Elmar Schnee told BioCentury. PDL BioPharma Inc. gained the program through its 2005 acquisition of ESP Pharma Inc....
BioCentury | Mar 17, 2008
Finance

Ebb & Flow

...Capital; and ESP Equity Partners. In 2003, GE Healthcare Financial Services helped finance EKR's predecessor, ESP Pharma...
BioCentury | Feb 11, 2008
Strategy

Sell high, buy low

...PDL BioPharma Inc. may not have gotten what it wanted from its 2005 purchase of ESP Pharma Inc....
BioCentury | Sep 3, 2007
Finance

PDL's downside surprise

...sales in 4Q07 or 1Q08. The marketed products came to PDLI through its acquisition of ESP Pharma Inc....
BioCentury | Aug 27, 2007
Finance

Ebb & Flow

...of Susquehanna, who upgraded from neutral to positive, valued a potential sale of the company's ESP Pharma...
BioCentury | May 14, 2007
Finance

Queen moves in PDL chess game

...2003 & Oct. 6, 2003). In last week's letter, Queen wrote that PDLI's purchase of ESP Pharma Inc....
BioCentury | Mar 12, 2007
Finance

Ebb & Flow

...and expeditious product development, you made what we consider to be an ill-conceived purchase of ESP Pharma,"...
BioCentury | Jan 22, 2007
Strategy

The ESP effect

...The ESP effect PDL BioPharma had a 95% runup from the time it acquired ESP Pharma in...
BioCentury | Jan 22, 2007
Strategy

Reset button

...channel. In 2005, he turned the company into a commercial enterprise with the acquisition of ESP Pharma Inc....
BioCentury | Jan 8, 2007
Finance

Value vs. opportunity

...thinks "expectations are low" for the products that PDLI gained from its 2005 acquisition of ESP Pharma...
Items per page:
1 - 10 of 54